MRGPRX1 is a G protein-coupled receptor specifically expressed in sensory neurons of the dorsal root ganglion that mediates itch perception and pain transmission 1. The receptor is activated by diverse ligands including enkephalin neuropeptides (BAM8-22, BAM22) 1, tick defensins 2, and conotoxin CNF-Tx2, inducing histamine-independent itch 1. MRGPRX1 activation triggers conformational changes that couple to both Gq and Gi G proteins: Gq coupling activates phospholipase C-beta to release second messengers (DAG and IP3) that sensitize TRPV1 in pruriceptors, while Gi coupling inhibits adenylate cyclase 1. Peripheral MRGPRX1 activation elicits itch and scratching behavior 2, whereas central nervous system activation by BAM8-22 dampens chr11 pain by preventing nociceptive signal transmission at spinal cord synapses 3. Recent structural studies reveal a shallow, plastic orthosteric binding pocket and unique features accommodating peptide C-terminal motifs 1. Clinically, MRGPRX1 represents a promising non-opioid analgesic target, with positive allosteric modulators showing efficacy in neuropathic pain models without inducing tolerance or adverse effects 3. Additionally, MRGPRX1 suppresses melanogenesis, suggesting roles in pigmentary disorders 4.